Ultragenyx Pharmaceutical Inc. logo

Ultragenyx Pharmaceutical Inc. (RARE)

Market Closed
5 Dec, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
36. 38
-0.16
-0.44%
$
3.25B Market Cap
- P/E Ratio
0% Div Yield
1,150,404 Volume
-8.23 Eps
$ 36.54
Previous Close
Day Range
35.94 37.25
Year Range
25.81 50
Want to track RARE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 67 days
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
12 Feb 2026 (In 2 months)
-
Cons. EPS
-
EPS
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
6 Nov 2025
-
Cons. EPS
-
EPS
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
4 Nov 2025
-
Cons. EPS
-
EPS
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
3 Nov 2025
-
Cons. EPS
-
EPS
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
31 Jul 2025
-
Cons. EPS
-
EPS
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
30 Apr 2025
-
Cons. EPS
-
EPS
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
13 Feb 2025
-
Cons. EPS
-
EPS
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
31 Oct 2024
-
Cons. EPS
-
EPS
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
1 Aug 2024
-
Cons. EPS
-
EPS
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
18 Jun 2024
-
Cons. EPS
-
EPS
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
2 May 2024
-
Cons. EPS
-
EPS
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
14 Feb 2024
-
Cons. EPS
-
EPS
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
31 Oct 2023
-
Cons. EPS
-
EPS
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
7 Nov 2016
-
Cons. EPS
-
EPS
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
8 Aug 2016
-
Cons. EPS
-
EPS
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
9 May 2016
-
Cons. EPS
-
EPS
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
25 Feb 2016
-
Cons. EPS
-
EPS
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
9 Nov 2015
-
Cons. EPS
-
EPS
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
13 Aug 2015
-
Cons. EPS
-
EPS
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
11 May 2015
-
Cons. EPS
-
EPS
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
25 Mar 2015
-
Cons. EPS
-
EPS
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
10 Nov 2014
-
Cons. EPS
-
EPS
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
11 Aug 2014
-
Cons. EPS
-
EPS
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
12 May 2014
-
Cons. EPS
-
EPS
Ultragenyx Pharmaceutical Inc. logo
RARE Ultragenyx Pharmaceutical Inc.
24 Mar 2014
-
Cons. EPS
-
EPS

RARE Earnings Reports FAQ

What is the earnings per share (EPS) for RARE?

The current EPS is -8.23.

What is the company's earnings growth rate?

Ultragenyx Pharmaceutical Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

The next earnings release is expected to be on 2026-02-12, based on the RARE's typical earnings announcement schedule.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Ultragenyx Pharmaceutical Inc are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for RARE at this time, as Ultragenyx Pharmaceutical Inc has no recent EPS data to calculate it.